COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?

Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangaraju, Pugazhenthan, Gurunthalingam, Meenalotchini P., Varthya, Shobanbabu, Venkatesan, Sajitha, Thangaraju, Eswaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380773/
https://www.ncbi.nlm.nih.gov/pubmed/32754467
http://dx.doi.org/10.4103/jfmpc.jfmpc_422_20
_version_ 1783562907526627328
author Thangaraju, Pugazhenthan
Gurunthalingam, Meenalotchini P.
Varthya, Shobanbabu
Venkatesan, Sajitha
Thangaraju, Eswaran
author_facet Thangaraju, Pugazhenthan
Gurunthalingam, Meenalotchini P.
Varthya, Shobanbabu
Venkatesan, Sajitha
Thangaraju, Eswaran
author_sort Thangaraju, Pugazhenthan
collection PubMed
description Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some emergency measure by pharmacological intervention till a newer drug available in the market.
format Online
Article
Text
id pubmed-7380773
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73807732020-08-03 COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings? Thangaraju, Pugazhenthan Gurunthalingam, Meenalotchini P. Varthya, Shobanbabu Venkatesan, Sajitha Thangaraju, Eswaran J Family Med Prim Care Invited Article Currently no drug is approved for the prophylaxis and management of COVID 19. Lots of activities on vaccine and trials with drugs are underway. Some evidence have shown positive results using older established drug in the management of severe cases. We are also of same view and opinion to adopt some emergency measure by pharmacological intervention till a newer drug available in the market. Wolters Kluwer - Medknow 2020-05-31 /pmc/articles/PMC7380773/ /pubmed/32754467 http://dx.doi.org/10.4103/jfmpc.jfmpc_422_20 Text en Copyright: © 2020 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Invited Article
Thangaraju, Pugazhenthan
Gurunthalingam, Meenalotchini P.
Varthya, Shobanbabu
Venkatesan, Sajitha
Thangaraju, Eswaran
COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title_full COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title_fullStr COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title_full_unstemmed COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title_short COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
title_sort covid-19: older drugs for a novel disease—chloroquine, hydroxychloroquine, and possible pentoxifylline—set to start the second innings?
topic Invited Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380773/
https://www.ncbi.nlm.nih.gov/pubmed/32754467
http://dx.doi.org/10.4103/jfmpc.jfmpc_422_20
work_keys_str_mv AT thangarajupugazhenthan covid19olderdrugsforanoveldiseasechloroquinehydroxychloroquineandpossiblepentoxifyllinesettostartthesecondinnings
AT gurunthalingammeenalotchinip covid19olderdrugsforanoveldiseasechloroquinehydroxychloroquineandpossiblepentoxifyllinesettostartthesecondinnings
AT varthyashobanbabu covid19olderdrugsforanoveldiseasechloroquinehydroxychloroquineandpossiblepentoxifyllinesettostartthesecondinnings
AT venkatesansajitha covid19olderdrugsforanoveldiseasechloroquinehydroxychloroquineandpossiblepentoxifyllinesettostartthesecondinnings
AT thangarajueswaran covid19olderdrugsforanoveldiseasechloroquinehydroxychloroquineandpossiblepentoxifyllinesettostartthesecondinnings

Ejemplares similares